02181 MABPHARM-B
- 0.350
- -0.035-9.09%
MABPHARM-B News
MABPHARM-B: 2024 Interim Report
MABPHARM-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
MABPHARM-B: DATE OF BOARD MEETING
MABPHARM-B: 2023 Annual Report
MABPHARM-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
MABPHARM-B: DATE OF BOARD MEETING
MABPHARM-B: 2023 Interim Report
MABPHARM-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2023
MABPHARM-B: DATE OF BOARD MEETING
MABPHARM-B: 2022 Annual Report
MABPHARM-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2022
MABPHARM-B: DATE OF BOARD MEETING
MABPHARM-B: 2022 Interim Report
MABPHARM-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
MABPHARM-B: DATE OF BOARD MEETING
MABPHARM-B: 2021 Annual Report
MABPHARM-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
MABPHARM-B: DATE OF BOARD MEETING
MABPHARM-B: 2021 Interim Report
MABPHARM-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021
Analysis
Price Target
No Data
No Data